Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B
Clinical trial NCT05905731 · UNKNOWN
Trial details
- NCT number
- NCT05905731
- Sponsor
- Beijing 302 Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.